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CD8+ T cells are an important arm of the adap-
tive immune system and play a prominent role 
in the host response to infection with a variety 
of  pathogenic  microorganisms,  most  notably 
infections by viruses and certain intracellular 
bacteria. These T cells exit the thymus as naive 
small quiescent lymphocytes. Upon encounter 
with the relevant antigen (pathogen epitope), 
naive CD8+ T cells undergo a programmed 
process of activation, proliferation, and differ-
entiation  into  effector  cells  (Lawrence  et  al., 
2005). Effector CD8+ T cells are typically gen-
erated within secondary lymphoid organs (i.e., 
LNs draining sites of infection) and then mi-
grate to extra lymphoid peripheral sites in re-
sponse  to  homing  signals  and  inflammatory 
stimuli produced by the pathogen (Lawrence   
et al., 2005). In response to encounter with the 
microorganism, effector CD8+ T cells use sev-
eral distinct effector mechanisms to eliminate 
the  pathogen,  most  notably  elaboration  of   
proinflammatory mediators (i.e., IFN-, TNF, 
and MIP-1; La Gruta et al., 2007) and direct 
destruction  of  infected  cells  by  perforin/ 
granzyme  and  proapoptotic TNF  receptor   
family–dependent mechanisms (Topham et al., 
1997; Brincks et al., 2008).
Both the activation of naive T lymphocytes 
and the expression of effector activity by acti-
vated CD8+ (and CD4+) T lymphocytes usually 
requires engagement of the TCR by peptide–
MHC  class  I  complexes  displayed  on APCs 
(Mescher  et  al.,  2007). This  initial  antigen- 
dependent signaling event can be modified by 
accessory signaling events involving direct T cell–
APC  contact  such  as  co-stimulatory  ligand– 
receptor  interactions  (Locksley  et  al.,  2001; 
Sharpe and Freeman, 2002), as well as engage-
ment of receptors on the responding T cells via 
soluble ligands such as cytokines (Mescher et al., 
2007). Depending on the nature of the stimu-
lus, engagement of the TCR and accessory signal-
ing can result in a variety of outcomes for the 
responding T cell ranging from full activation/
differentiation  through  to  aborted  activation 
and anergy (Mescher et al., 2007; Ream et al., 
2010). Although the impact of the strength of 
signaling through the TCR and accessory inter-
actions has been explored primarily during   
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Cytotoxic T lymphocytes (CTLs) play a prominent role in the resolution of viral infections 
through their capacity both to mediate contact-dependent lysis of infected cells and to 
release soluble proinflammatory cytokines and chemokines. The factors controlling these 
antiviral effector activities in vivo at infection sites are ill defined. Using a mouse model of 
influenza infection, we observed that the expression of CTL effector activity in the infected 
lungs is dictated by the target cell type encountered. CD45+ lung infiltrating inflammatory 
mononuclear cells, particularly CD11chi dendritic cells, trigger both CTL cytotoxicity and 
release of inflammatory mediators, whereas CD45 influenza-infected respiratory epithe-
lial cells stimulate only CTL cytotoxicity. CTL proinflammatory mediator release is modu-
lated by co-stimulatory ligands (CD80 and CD86) expressed by the CD45+ inflammatory 
cells. These findings suggest novel mechanisms of control of CTL effector activity and  
have potentially important implications for the control of excess pulmonary inflammation 
and immunopathology while preserving optimal viral clearance during respiratory  
virus infections.
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that influenza-infected CD45 respiratory epithelial cells can 
be recognized and lysed by effector CD8+ T cells; however, 
this interaction does not trigger proinflammatory cytokine 
production by the responding T cells. The implications of 
these findings for influenza pathogenesis and CD8+ T cell 
function are discussed.
RESULTS
Kinetics of CD8+ T cell accumulation, in vivo effector 
activity, and virus clearance during experimental  
influenza infection
Infected respiratory epithelial cells are an important target of 
the immune response because these cell types support pro-
ductive infection by influenza viruses; therefore, limiting in-
fection  of  these  cells  is  essential  for  virus  clearance  and 
recovery (Hou and Doherty, 1995; Topham et al., 1997). Be-
cause of the importance of these airway lining cells as targets 
for both the virus and effector CD8+ T cells, we analyzed the 
kinetics of influenza-specific CD8+ T cell accumulation si-
multaneously in the airspaces (cells overlaying the respiratory 
epithelium as collected in the bronchial alveolar lavage [BAL] 
fluid) and, in parallel, the subepithelial interstitial compart-
ment (pulmonary interstitium) after sublethal experimental 
A/PR/8/34 influenza infection of BALB/c mice. We quanti-
fied the numbers of influenza-specific IFN-–secreting CD8+ 
T cells in these two lung compartments over time using the 
in vitro intracellular cytokine staining (ICCS) assay.
As Fig. 1 A demonstrates, virus-specific effector CD8+  
T cells were first detectable in the respiratory tract between   
5 and 6 d postinfection (dpi) and increased rapidly in both the 
airspaces and interstitium between 6 and 10 dpi, confirming 
earlier results from several laboratories (Tripp et al., 1995; 
Crowe et al., 2003; Lawrence and Braciale, 2004). The kinetics 
of release of the signature effector T cell proinflammatory   
cytokine, IFN-, into the BAL fluid during infection (Fig. 1 B) 
reflected the onset of effector T cell accumulation into the 
infected lungs (i.e., at 5 dpi) and reached maximum levels in 
the BAL fluid at 6 and 7 dpi. IFN- release into the BAL fluid 
dropped  precipitously  thereafter,  commensurate  with  the 
clearance of infectious virus from the infected lungs (Fig. 1 C). 
In vivo T cell depletion analysis established CD8+ T cells as 
major contributors to IFN- production (Fig. S1 A) and virus 
clearance (Fig. S1 B). Comparable results were obtained in 
the analysis of infected C57BL/6 mice (unpublished data).
CD8+ T cells expressing proinflammatory cytokines in 
response to influenza infection localize principally in the 
infected lung interstitial compartment, not in the airspaces
When the proinflammatory effector cytokine response (i.e., 
IFN- production) in the infected lungs was at its peak (Fig. 1 B), 
relatively few influenza-specific effector CD8+ T cells had   
accumulated in the infected lungs. The majority of these ef-
fector cells were localized to the pulmonary interstitium with 
20–40-fold fewer effector CD8+ T cells localized to the airspace 
(Fig. 1 A). Because elimination of infected respiratory epithe-
lial cells was essential for virus clearance but the majority of 
naive T  cell  activation  (Locksley  et  al.,  2001;  Sharpe  and   
Freeman, 2002), the expression of effector activity by fully 
differentiated effector T cells may likewise be regulated by the 
sum  of  antigen-dependent  and  accessory  signaling  events 
(Locksley et al., 2001; Sharpe and Freeman, 2002). Indeed, it 
has been demonstrated in vitro that there is a hierarchy of   
expression of effector activities by CD8+ T cells based on   
the strength of the antigenic stimulus to the CD8+ T cell   
(Valitutti et al., 1996; Hemmer et al., 1998; Gehring et al., 
2007), although the in vivo significance of such a hierarchy is 
for the most part unknown.
Influenza virus is a major human pathogen that in its pan-
demic form has the potential to produce, on a global scale, se-
vere  infections  of  the  respiratory  tract,  resulting  in  excess 
morbidity and mortality (Neumann et al., 2009). In most in-
stances, influenza infection is restricted to the respiratory tract. 
Respiratory epithelial cells are the primary targets both for in-
fluenza virus replication (La Gruta et al., 2007) and for the host 
response  to  influenza  infection  (Hou  and  Doherty,  1995; 
Topham et al., 1997), as these CD45 cell types are, with rare 
exceptions, the only cell types capable of supporting produc-
tive virus infection (release of infectious virions from the in-
fected cell). Other cell types (i.e., CD45+ mononuclear cells) 
can be infected by influenza but typically do not produce fully 
infectious virions (Hao et al., 2008; Manicassamy et al., 2010).
Severe lower respiratory tract influenza infection results in 
marked inflammation in the infected lungs (La Gruta et al., 
2007). Although infection with influenza virus is lytic and 
usually results in the death of the infected cells (Fesq et al., 
1994), there is a considerable body of evidence to suggest that 
the host immune response to infection, including the CD8+ 
T cell response, is a major contributor to the pulmonary in-
flammation and morbidity associated with infection and the 
process of virus clearance (Enelow et al., 1998; La Gruta et al., 
2007). In particular, proinflammatory cytokines/chemokines 
released by innate and adaptive immune cells while acting to 
suppress the virus replication may also promote pulmonary 
inflammation and injury when produced in excess (Peper and 
Van Campen, 1995; Hussell et al., 2001; La Gruta et al., 2007; 
Sun and Metzger, 2008). Thus, understanding the factors reg-
ulating proinflammatory cytokine production and their rela-
tionship to the mechanism of virus clearance is important for 
a detailed understanding of influenza pathogenesis.
In this study, we evaluated the proinflammatory cytokine 
response of virus-specific effector CD8+ T cells responding in 
the infected lungs to sublethal influenza virus infection. We 
found that proinflammatory cytokine production by the ef-
fector CD8+ T cells was largely, if not exclusively, restricted to 
the T cells localized to the pulmonary interstitium. This anti-
gen-driven  proinflammatory  cytokine  production  was  de-
pendent on T cell interaction with CD45+ (predominantly 
CD11c+) inflammatory cells infiltrating the infected lungs. 
Blockade of CD80 and CD86 co-stimulation at the time of 
effector CD8+ T cells migration into the lungs inhibited pro-
inflammatory cytokine production by the T cells. In related 
experiments, we provide evidence both in vivo and in vitro JEM VOL. 208, January 17, 2011 
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IFN- accumulation by CD8+ T cells (see Fig. S2 for details 
of assay optimization).
Unexpectedly,  we  found  that,  throughout  infection,  a 
much larger fraction of in vivo IFN-–secreting CD8+ T cells 
was localized in the pulmonary interstitium than in the air-
spaces (Fig. 1 D and Fig. S2 D). At the time of peak IFN- 
release into the BAL fluid (6–7 dpi), the total number of in 
vivo IFN-+CD8+ T cells in the interstitium exceeded those 
in the airspaces by >100-fold (Fig. 1 E). It is also noteworthy 
that the numbers of CD8+ T cells scoring positive for IFN- 
influenza-specific CD8+ T cells were localized to the intersti-
tium at this time, we wanted to establish the contribution, if 
any, of these interstitial CD8+ T cells to the IFN- response 
detected in the BAL fluid. To explore this possibility, we used 
a modified version of the in vivo ICCS assay (Liu and Whitton, 
2005) to identify and determine the kinetics of IFN-– 
secreting CD8+ T cells accumulating and responding in vivo. 
In brief, brefeldin A (BFA) was introduced into the respira-
tory tract intranasally (i.n.) 6 h before harvest of the infected 
lungs, followed by direct ex vivo analysis of intracellular   
Figure 1.  Antigen-dependent CD8+ T cell IFN- protein production in situ. (A–F) A/PR/8-infected BALB/c mice were analyzed on the indicated dpi. 
(A) Airspace (BAL fluid) and interstitial (lung suspensions) cells were sampled and identified by IFN- production after in vitro restimulation with influ-
enza-infected P815 cells. (B and C) IFN- protein (B) and viral titers (TCID50; C) in BAL fluid samples with horizontal line detection limit. (D and E) In situ 
CD8+ T cell IFN- protein production using in vivo ICCS assay at the indicated dpi. Representative flow profiles (D) and absolute numbers of activated 
(Ly6Chi) CD8+ T cells producing IFN- protein in situ (E) are shown. (A–E) Two to five independent experiments (n = 8–20 mice) as mean ± SEM are shown. 
Considered significant with respect to 0 dpi at *, P < 0.05. (F) Antigen dependence of IFN- production. CL-4 T cell (Thy1.1) congenic recipients (Thy1.2) 
were infected with A/PR/8 influenza virus. At 6 dpi, purified CD8+ cells (5 × 105) from recipient lung were transferred i.v. into 5 dpi X31- or PR8-infected 
congenic mice (Thy1.2) and evaluated with the in vivo ICCS assay 24 h later. Flow profiles of IFN-+ CL-4 T cells are representative of four independent 
experiments (n = 2/experiment).170 Effector T cell activity controlled by target type | Hufford et al.
fraction (40–50%) of the CL-4 T cells isolated from the 
lung interstitium had produced IFN- protein in vivo at   
6 dpi, whereas IFN-+ CL-4 T cells were not detected among 
cells isolated from the airspaces (Fig. S4 D).
To directly establish that IFN- production by the virus-
specific effector CD8+ T cells in the interstitium was depen-
dent on specific antigenic stimulation, effector CL-4 T cells 
isolated from the lungs of infected mice were transferred into 
either A/PR/8- or A/X31-infected recipients at 5 dpi, the 
time of peak virus titer and the initial onset of effector CD8+ 
T cell accumulation in the infected lungs (Fig. 1, B and C).   
24 h later, effector CL-4 T cells transferred into the A/PR/ 
8-infected recipient demonstrated robust IFN- synthesis in 
the in vivo ICCS assay. In stark contrast, effector CL-4 T cells 
transferred into mice infected with the antigenically distinct, 
mouse-adapted  A/X31  virus,  which  lack  the  HA533–541  
epitope recognized by the CL-4 T cells, showed minimal re-
sponsiveness, confirming the antigen dependence of proin-
flammatory  cytokine  production  during  the  height  of  an 
influenza infection (Fig. 1 F).
Proinflammatory cytokine production by antiviral effector 
CD8+ T cells requires MHC class I expression only on CD45+ 
hematopoietic cells in the infected lung
The accumulating data from our analysis to this point suggested 
that it was virus-specific CD8+ T cells localized to the infected 
lung interstitium which exhibited in vivo antiviral effector ac-
tivity at least as defined by antigen-dependent production of 
proinflammatory cytokines. Accordingly, effector CD8+ T cells 
encountering and engaging the infected respiratory epithelium 
in the airspaces, paradoxically, were contributing little to this ef-
fector T cell response. Infection of the mouse respiratory tract 
by influenza virus results not only in recruitment of effector 
CD8+ T cells to the infected lungs but also in a progressive in-
flux of CD45+ inflammatory myeloid-derived cells into the 
pulmonary interstitium (La Gruta et al., 2007), which peaks at 
the time of effector T cell influx into the infected lungs. These 
considerations raised the possibility that the interaction of ef-
fector CD8+ T cells with CD45+ inflammatory cells within the 
interstitium, rather than with influenza-infected CD45 respi-
ratory epithelial cells, accounted for preferential expression of 
effector activity by the interstitial virus-specific T cells.
To further explore this possibility, we constructed BM 
chimeras in which irradiated MHC class Ia–deficient (and as 
controls irradiated MHC class Ia–sufficient WT) mice were 
reconstituted with MHC class I–sufficient BM from Rag1/ 
donors (Fig. 2 A). Rag1/ BM was used for reconstitution 
to avoid the development of MHC class Ib–restricted antivi-
ral T cells (Swanson et al., 2008) and to assure that respiratory 
DCs expressing MHC class I would be present to serve as APCs 
during the induction of antiviral CD8+ T cell responses in both 
the experimental and control chimeras (GeurtsvanKessel   
et al., 2008; Kim and Braciale, 2009). After reconstitution, 
both sets of mice were MHC class I sufficient in the CD45+ 
hematopoietic compartment (including tissue-resident DCs, 
macrophages, and infiltrating inflammatory mononuclear 
in the in vivo ICCS assay over time (Fig. 1 E) directly paralleled 
the kinetics of IFN- release into the BAL fluid (Fig. 1 B). 
Comparable differences in the responsiveness of the intersti-
tial and airspace CD8+ T cells were observed independent of 
the i.n. BFA dose administered (Fig. S2 B) and were also ob-
served after i.n. administration of the protein transport inhibi-
tor monensin (Fig. S2 C).
The aforementioned findings raised the possibility that 
the effector CD8+ T cells localized to the interstitium were 
the primary, if not exclusive, source of the IFN- released 
into the BAL fluid as they represented both the quantitatively 
larger fraction of effector CD8+ T cells in the infected lungs 
and were the major IFN-–secreting cells detected in the   
in vivo ICCS assay. Additionally, the data suggested that the 
effector CD8+ T cells localized to the airspaces may be poorly 
responsive to antigenic stimulation; however, when we exam-
ined the ability of CD8+ T cells isolated from the airspaces or 
interstitium to respond to antigenic stimulation in vitro in the 
ICCS assay, both T cell populations responded with compara-
ble efficiency (Fig. S3, A and B). In keeping with these results, 
we found that after in vitro antigenic stimulation, both airway 
and interstitial CD8+ T cells could transiently up-regulate cell 
surface expression of CD107a/b, a surrogate for granule exo-
cytosis–dependent cytotoxicity (Fig. S3 C; Betts et al., 2003). 
By these criteria, the effector CD8+ T cells in the two com-
partments were equally competent to respond to viral anti-
genic stimulation.
We were able to further confirm the findings obtained 
with the in vivo ICCS assay at the level of IFN- gene tran-
scription. Using  YETI mice, which express  YFP driven off the 
IFN- promoter (Mayer et al., 2005), we evaluated IFN- 
gene transcription in tetramer+CD8+ T cells during the peak 
of  proinflammatory  cytokine  release  (6  dpi;  Fig.  S4 A).   
We found that consistent with the in vivo ICCS results,   
both  the  number  and  percentage  of  influenza  polymerase 
tetramer+CD8+ T cells expressing YFP in the interstitium far 
exceeded those localized to the airspace (Fig. S4, B and C). 
We also noted apparent differences between interstitial and 
airway CD8+ T cells in the production of several other proin-
flammatory T  cell  cytokines/chemokines  in  vivo,  notably 
TNF (unpublished data).
Proinflammatory cytokine production by interstitial  
virus-specific CD8+ T cells is dependent on specific 
antigenic stimulation
To further investigate the regulation of the proinflammatory 
cytokine IFN- by interstitial (and airspace)-localized, virus-
specific CD8+ T cells, we performed adoptive transfer of pu-
rified CD8+ T cells from the TCR transgenic (tg) CL-4 mice 
into naive recipients. These TCR tg T cells are directed to a 
specific epitope in the hemagglutinin (HA) of A/PR/8 virus 
(HA533–541). After transfer of the T cells into Thy1 congenic 
recipients and subsequent infection of recipient mice with   
A/PR/8 virus, the frequency of IFN-–expressing CL-4 T cells 
in vivo was analyzed in the in vivo ICCS assay. Consistent 
with our observations with polyclonal CD8+ T cells, a large JEM VOL. 208, January 17, 2011 
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responding antiviral CD4+ T cells, as administration of depleting 
-CD4 antibody during infection reduced IFN- production 
by both CD45MHC class I and CD45MHC class I+ mice 
to the same extent (Fig. 2 E). It is also noteworthy that infec-
tious virus titers at 7 dpi were comparable in the lungs of 
CD45MHC class I and CD45MHC class I+ mice and were 
statistically indistinguishable from those of unmanipulated WT 
infected animals (Fig. 2 F). Both chimeric mouse cohorts elimi-
nated infectious virus by 10 dpi (Fig. 2 F). Equivalent viral elim-
ination between the chimeric mice was not unexpected, though, 
considering the well documented combined contribution of 
effector CD4+ T cells and antiviral B cells as efficient mecha-
nisms for the control of infectious virus titer in the absence of 
effector CD8+ T cell function (Topham et al., 1996; Topham 
and  Doherty,  1998). Thus,  deficiencies  in  triggering  CD8+  
T cell effector activity in CD45MHC class I mice would 
have minimal consequences on eventual viral clearance without 
additional manipulation.
Ablation of CD11chi mononuclear cells in the infected  
lungs inhibits proinflammatory cytokine production  
by antiviral CD8+ T cells
The aforementioned results supported the possibility that anti-
viral effector CD8+ T cells were engaging CD45+ cells in the 
cells in the infected lungs) and either MHC class I deficient 
or sufficient among CD45 cells (including the respiratory 
epithelium). These CD45MHC class I and CD45MHC 
class I+ mice received, by adoptive transfer, WT splenocytes as 
a source of mature lymphocytes. The mice were subsequently 
infected, and T cell effector activity and antiviral responses 
were analyzed at 7 dpi (Fig. 2 A).
We analyzed the number and frequency of IFN-–secreting 
CD8+ T cells by the in vivo ICCS assay and IFN- release into 
the BAL fluid in infected chimeric mice. We found that the   
frequency (Fig. 2 B) and absolute number (Fig. 2 C) of IFN-
+CD8+ T cells localized to the interstitium by the in vivo 
ICCS assay were comparable for CD45MHC class I and 
CD45MHC class I+ mice. Equally important, the frequency 
(Fig. 2 B) and number (Fig. 2 C) of IFN-+CD8+ T cells in the 
airspaces were unaffected by the presence or absence of MHC 
class I expression by respiratory epithelial cells. In keeping with 
these findings, ELISA quantitation of IFN- protein in the BAL 
fluid revealed no difference in the ability of these mice to release 
the proinflammatory cytokine during an influenza infection 
(Fig. 2 D). The levels were comparable with those seen in non-
irradiated controls at this point in infection. Furthermore, the 
level of IFN- in the BAL fluid of CD45MHC class I was 
not caused by a compensatory increase in IFN- production by 
Figure 2.  Impact of MHC I–deficient respiratory epithelial cells on CD8+ T cell cytokine production after influenza infection. (A) Irradiation 
BM chimera schematic. Infected chimeric mice were examined at 7 dpi unless noted elsewhere. (B and C) In situ CD8+ T cell IFN- protein production 
using in vivo ICCS assay. Representative flow profiles (B) and absolute numbers of IFN-+CD8+ T cells in situ (C) are shown. (D) BAL fluid IFN- release.  
(E) Infected mice were depleted of CD4+ cells (3 dpi), and BAL fluid IFN- protein content was determined (7 dpi). (D and E) WT equals control infected 
mice. (F) Viral titers (TCID50) in BAL fluid at the indicated times postinfection with horizontal detection limit. (B–F) Four independent experiments  
(n = 8–12 mice) as mean ± SEM are shown. FMO, fluorescence minus one.172 Effector T cell activity controlled by target type | Hufford et al.
CD8+ T cells, we evaluated the impact of depletion/ablation 
of this mononuclear cell population from the infected lungs on 
the production of IFN- by effector CD8+ T cells in vivo.
We used CD11c–diphtheria toxin receptor (DTR) mice 
to investigate the effect of depletion on CD8+ T cell proin-
flammatory cytokine production during an influenza infec-
tion. These mice express the primate DTR driven off of the 
CD11c promoter, and we have previously shown that i.n. ad-
ministration of toxin efficiently depletes CD11chi cells from 
the respiratory tract (Kim and Braciale, 2009). Because toxin 
administration at the initiation of virus infection eliminates 
respiratory DCs and, as a consequence, profoundly inhibits 
the induction of the virus-specific effector CD8+ T cell re-
sponse (Kim and Braciale, 2009), we delayed toxin adminis-
tration until 5 dpi, which is 24 h before the peak of CD8+  
T cell effector activity. Toxin administration led to a substan-
tial reduction of CD11chi cells in DTR (+) but not in control 
DTR () mice at 6 dpi (Fig. 3 A). When we analyzed IFN- 
release into the BAL fluid after toxin administration, we found 
that depletion of CD11chi cells at the time of effector CD8+ 
T cell influx into the infected lungs markedly suppressed IFN- 
production  24  h  later  (Fig.  3  B),  which  was  as  expected  if 
CD45+CD11chi cells were the primary APC for (trigger of) 
inflammatory cytokine/chemokine production by the T cells.
Because after activation and migration to inflamed sites like 
the infected lungs some CD8+ T cells can express low levels of 
CD11c, CD8+ T cells from CD11c-DTR mice may also be de-
pleted  in  the  lungs  after  toxin  administration  (Bennett  and   
Clausen, 2007). To further establish that elimination of CD11chi 
APCs  from  the  infected  lungs  inhibits  proinflammatory   
inflamed pulmonary interstitium to trigger effector cytokine 
production. As demonstrated above, IFN- production by the 
effector CD8+ T cells required specific antigen recognition 
(Fig. 1 F). Accordingly, CD45+ inflammatory cells in the in-
terstitium should contain viral antigen capable of being pre-
sented to effector CD8+ T cells and therefore serve as target 
cells (APCs). Indeed, we could detect influenza nucleocapsid 
protein (NP) in both CD45+ hematopoietic/inflammatory 
cells as well as CD45 cells (including respiratory epithelial   
cells) isolated from the infected lungs at the peak of inflam-
matory cytokine production (Fig. S5 A), suggesting that   
viral antigen was localized to both cell populations. However, 
the viral antigen displaying CD45+ cells and not the virus- 
infected, antigen-expressing CD45 respiratory epithelial 
cells trigger the proinflammatory cytokine response of effec-
tor CD8+ T cells.
Several different inflammatory cell subsets infiltrating the 
influenza-infected lungs (including DCs and Ly6Chi inflam-
matory macrophages) have been reported to have APC activ-
ity (Lin et al., 2008; McGill et al., 2008) and would be likely 
candidates to serve as target cells regulating the proinflamma-
tory cytokine production by effector CD8+ T cells. These DC 
and macrophage subsets (CD45+, GR1int, CD11bhi, MHC 
class  II+,  inflammatory  mononuclear  cells)  accumulate  in 
large numbers at 6–7 dpi (Fig. S5 B), which is at the peak of 
expression of CD8+ T cell effector activity, and can take up 
and display influenza viral NP protein (Fig. S5 C). Importantly, 
these mononuclear cells within the inflamed lung intersti-
tium express high levels of CD11c (Fig. S5 D). To assess the 
role of these CD11c+ inflammatory cells as APCs for effector 
Figure 3.  The impact of acute CD11chi 
cell depletion on in vivo CD8+ T cell IFN- 
production. (A and B) Infected CD11c-DTR  
tg (+) and DTR non-tg () mice were treated 
with diphtheria toxin at 5 dpi. Representative 
flow profile of CD11chiMHC IIhi cell depletion 
in lung cell suspensions (6 dpi; A) and BAL 
fluid IFN- release (6 dpi; B) are shown.  
(C–F) Transferred tg CL-4 T cells into Thy-
mismatched congenic CD11c-DTR (+) and DTR 
() mice. Infected mice received diphtheria 
toxin (5 dpi), and on 6 dpi, mice were inter-
rogated for in vivo IFN- production by  
the in vivo ICCS assay (i.p. monensin).  
(C and D) Representative flow profiles (C) and 
percentage of IFN-+ tg CL-4 T cells in vivo 
(D) are shown. (C and E) IFN- production 
after in vitro restimulation with influenza-
infected P815 cells. (E) Number of tg CL-4  
T cells present in the total lung cell suspen-
sions is shown. (G) Viral titers (TCID50) in sam-
ple BAL fluid with horizontal detection limit.  
(A–G) Two to four independent experiments  
(n = 8–16 mice) as mean ± SEM are shown. 
Considered a significant difference at  
*, P < 0.05.JEM VOL. 208, January 17, 2011 
Article
173
2001; Sharpe and Freeman, 2002). Because the co-stimulatory 
ligands CD80 and CD86 are expressed at high levels on 
CD45+CD11chi  cells  in  the  infected  lung  interstitium  and 
only minimally expressed on CD45 lung cells, including the 
infected respiratory epithelium (Fig. 4 A), we wished to de-
termine whether co-stimulatory ligand–receptor-dependent 
interaction between the CD45+ lung APCs and antiviral effec-
tor CD8+ T cells regulated IFN- production by the T cells.
To  evaluate  this,  C57BL/6  mice  were  infected  with   
A/PR/8/34 virus, and at 5 dpi, a blocking CD80 and CD86   
antibody cocktail was administered i.p. 24 h later, BAL fluid was 
collected  and  analyzed  for  IFN-  production  (Fig.  4  B).   
We observed that short-term acute CD80 and CD86 blockade 
at the time of effector CD8+ T cell influx into the infected 
lungs led to a significant decline in IFN- secretion. The re-
duction coincided with a corresponding reduction in IFN-
–producing CD8+ T cells in vivo (Fig. 4 C). Of particular note, 
in vivo blockade of co-stimulatory receptor–ligand interactions 
between effector T cells and the CD45+ APC did not affect   
virus clearance from the infected lungs (Fig. 4 D). Compara-
ble results were obtained after acute CD80 and CD86 block-
ade in influenza-infected BALB/c mice (Fig. S5, E–G). The 
capacity for CD8+ T cells to release IFN- was not altered in 
mice receiving acute administration of CD80 and CD86, as 
these cells responded equally well compared with CD8+  
T cells from mice receiving isotype antibody when restimu-
lated with influenza-infected CD45+ cells in vitro (Fig. S5 H). 
Altogether, these data suggest that CD80 and CD86 signaling 
was necessary for maximal proinflammatory cytokine pro-
duction by effector CD8+ T cells responding to infection.
Effector CD8+ T cell interactions with infected CD45 
respiratory epithelial cells signal for T cell–mediated 
cytolysis but not proinflammatory cytokine production
The aforementioned results raised the unexpected as well as 
unlikely  possibility  that  the  response  of  the  virus-specific   
cytokine production by the responding CD8+ T cells, we ana-
lyzed the response of Thy-mismatched WT CL-4 tg T cells to 
influenza infection after adoptive transfer of the T cells into 
CD11c-DTR mice and toxin treatment at 5 dpi. We observed 
that the depletion of CD11chi cells was accompanied by an 
50% reduction in the percentage of activated effector CL-4   
T cells producing IFN-, as determined via the in vivo ICCS 
assay (Fig. 3, C and D). Depletion of the CD11chi cells at 5 dpi 
did not alter the activation state of the CD8+ T cells as ex vivo 
restimulation of the transferred CL-4 T cells resulted in the 
equivalent IFN- production by CL-4 T cells isolated from con-
trol and depleted mice at 6 dpi (Fig. 3, C and E). Furthermore, 
depletion of CD11chi cells did not have significant impact on the 
ability of CL-4 T cells to migrate/accumulate in the inflamed 
lung, as comparable numbers of CL-4 T cells were present in 
DTR () and DTR (+) mice at 6 dpi (Fig. 3 F). These results 
provide additional support for the concept that CD45+CD11c+ 
inflammatory mononuclear cells primarily residing in the pul-
monary interstitium serve as the dominant APCs (and possibly a 
primary target) for the production of proinflammatory cyto-
kines by antiviral effector CD8+ T cells in the influenza-infected 
lungs. Of particular note, the depletion of the CD45+CD11c+ 
APCs and the attendant decrease in IFN- production by the 
effector CD8+ T cells had minimal impact on the control of   
virus replication in the infected lungs (Fig. 3 G).
Efficient expression of the proinflammatory cytokines  
by effector CD8+ T cells requires co-stimulation
Engagement of the TCR is essential for activation of naive   
T cells as well as the expression of effector activity by activated 
T cells. Similarly, engagement of co-stimulatory receptors (e.g., 
CD28) by their requisite co-stimulatory ligands (e.g., CD80 
and CD86) is also normally required for full T cell activation 
and differentiation, and in certain instances, these interactions 
have  been  demonstrated  to  modulate  both T  cell  effector   
activity and the T cell response to pathogens (Locksley et al., 
Figure 4.  The impact of acute CD80 and CD86 blockade on in vivo T cell IFN- production during an influenza infection. (A) Lung suspen-
sions were collected from 6 dpi C57BL/6 mice. Flow profile represents the expression of CD80 and CD86 on CD11chi cells (solid line; CD45+CD11b+CD11chi) 
and CD45 cells (dashed line) in comparison with isotype control antibody (shaded region). (B–D) A/PR/8-infected C57BL/6 mice received CD80 and CD86 
blocking or isotype control antibody cocktail i.p. at 5 dpi. (B) BAL fluid IFN- release (6 dpi). (C) An in vivo ICCS assay (i.p. monensin) at 6 dpi. Graph de-
picts total lung CD8+ T cells producing IFN- protein in vivo. (D) Viral titers (TCID50) in sample BAL fluid with horizontal line detection limit. (A–D) Two 
independent experiments (n = 8 mice) as mean ± SEM are shown. Considered a significant difference at *, P < 0.05.174 Effector T cell activity controlled by target type | Hufford et al.
CD4+ T cells (Fig. 5 A). This depletion effectively eliminated 
CD4+ antiviral activity as well as impacted the production of 
isotype-switched antibody. After infection, daily weights were 
obtained as a measure of systemic morbidity, and mice were 
evaluated for virus titer, infected cell numbers, and cytokine 
production at 7, 10, and 14 dpi.
As expected, experimental and control of infected chime-
ric mice exhibited similar kinetics of initial weight reduction 
after sublethal i.n. infection, which was maximal at 7–10 dpi 
(Fig. 5 B). However, unlike WT chimeric mice (WT → WT), 
which exhibited the normal pattern of recovery and weight 
gain beyond 10 dpi, mice deficient in both perforin and FAS 
(Perf/ → FAS/) failed to recover and sustained low body 
weight until the termination of the experiment (Fig. 5 B). 
Chimeric mice that were sufficient in perforin expression by 
CD8+  effector T  cells  but  deficient  in  Fas  expression  on 
CD45 respiratory epithelial cells (WT → FAS/) exhib-
ited  a  slightly  delayed  time  course  of  weight  gain  and   
recovery (Fig. 5 B). These results correlated with the kinet-
ics of virus clearance from the infected respiratory tract.   
WT → WT mice had, as expected, cleared infectious virus 
from the respiratory tract by 10 dpi, whereas significant virus 
titers were detected in both the WT → FAS/ and Perf/ 
→ FAS/ mice at this time point (Fig. 5 C). By 14 dpi,   
infectious virus was no longer at statistically elevated levels   
in WT  →  FAS/  mice,  but  substantial  virus  titers  were   
detected at this time in the infected Perf/ → FAS/ chi-
meras (Fig. 5 C).
We also examined the number of 
infected CD45 respiratory epithelial 
cells present over time in the lungs of 
these infected chimeric mice by flow 
cytometry. We focused on epithelial cells 
liberated from infected airways (identi-
fied by the expression of the cell surface 
marker epithelial cell adhesion mole-
cule  [Ep-CAM];  Kasper  et  al.,  1995) 
effector CD8+ T cells was directed primarily to CD45+CD11chi 
mononuclear cells and that infected respiratory epithelial cells 
were only a secondary target or perhaps not directly recog-
nized. This latter possibility seemed unlikely, as suppression of 
virus replication in respiratory epithelial cells is critical for   
virus clearance and recovery (Hou and Doherty, 1995; Topham 
et al., 1997). In this connection, it is noteworthy that an ear-
lier study implicated the expression of perforin and FAS   
cytotoxic pathways in CD8+ T cell–mediated control of virus 
replication in the respiratory tract (Topham et al., 1997). Ac-
cordingly, effector CD8+ T cell–dependent clearance of influ-
enza-infected cells, in particular elimination of CD45-infected 
respiratory epithelial cells, would be dependent on the opera-
tion of one or both of these cytolytic effector mechanisms.
To reevaluate the contribution of perforin- and/or FAS-
dependent cytotoxicity by effector CD8+ T cells on infec-
tious virus clearance and the impact of these cytolytic effector 
mechanisms on the elimination of virally infected CD45  
in vivo (Topham et al., 1997), we constructed BM chimeras 
in which irradiated FAS-deficient mice (and as controls irra-
diated FAS-sufficient WT mice) were reconstituted with BM 
from either WT or perforin-deficient mice (Fig. 5 A). This 
resulted in experimental mice that were selectively deficient 
in perforin expression in the effector CD8+ T cells or FAS 
expression selectively on CD45 respiratory epithelial cells or 
both. To examine the impact of effector CD8+ T cells exclu-
sively on influenza virus clearance in vivo after reconstitution, 
experimental and control chimeric mice were depleted of 
Figure 5.  The impact of FAS and  
perforin deficiency on CD8+ T cell– 
mediated viral clearance during an influ-
enza infection. (A) Irradiation BM chimera 
schematic. After reconstitution (≥45 d), mice 
were infected and depleted of CD4+ cells at  
0 and 7 dpi. (B) Percent body weight loss (with 
respect to 0 dpi body weight) in chimeric mice. 
(C) Viral titers (TCID50) in sample BAL fluid from 
indicated dpi with horizontal line detection 
limit. (D and E) Absolute number of influenza-
infected Ep-CAM+ (D) and T1+ (E) epithelial 
cells (CD45 autofluorescentHA+NP+) sample 
from lung suspensions at indicated dpi. (B–E) 
Four independent experiments (n = 8 mice) as 
mean ± SEM are shown. Considered a signifi-
cant difference with respect to WT reconsti-
tuted control difference at given dpi  
(*, P < 0.05).JEM VOL. 208, January 17, 2011 
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L929 fibroblast cell line were as equally efficient in initiating 
CD8+ T cell degranulation as the infected CD45+ BM-derived 
DCs (BMDCs; Fig. 6 A). In marked contrast, only BMDCs 
were capable of triggering efficient IFN- production by the 
effector CD8+ T cells from the infected lungs (Fig. 6 B).
In view of the impact of CD80 and CD86 blockade in 
the infected lungs on proinflammatory cytokine production 
by effector CD8+ T cells in vivo (Fig. 4), we wanted to deter-
mine  whether  blockade  of  co-stimulatory  receptor–ligand 
interactions in vitro also affected the ability of lung-derived 
effector CD8+ T cells to produce IFN- in response to stimu-
lation by the infected CD45+ cells. CD8+ T cells were co-
cultured with infected BMDCs in the presence of blocking 
antibodies  to  CD80  and  CD86  co-stimulatory  molecules. 
The presence of these blocking antibodies diminished the abil-
ity of BMDCs to stimulate T cell IFN- production (Fig. 6 C) 
while not affecting the ability of these target cells to trigger 
the granule exocytosis–cytolysis effector pathway (i.e., tran-
sient up-regulation of CD107a/b) by the CD8+ T cell effec-
tors (not depicted).
DISCUSSION
In this study, we examined the effector CD8+ T cell response 
to influenza virus infection in the respiratory tract and the 
factors ultimately regulating it. This analysis focused on the 
kinetics of CD8+ T cell accumulation, the localization of ef-
fector CD8+ T cells within the infected lungs, and the local-
ization of CD8+ T cell effector activity within the pulmonary 
interstitium and airspaces. We observed that proinflammatory 
cytokine production (e.g., IFN- production) by effector 
CD8+ T cells was detected at maximum levels during the 
early phase of effector CD8+ T cell recruitment into the in-
fected lungs (i.e., 6–7 dpi). Effector cytokine release decreased 
with virus clearance. Quantitation of effector CD8+ T cells in 
the lung interstitium and in the airspaces (identified in col-
lected BAL fluid) indicated that influenza-specific CD8+  
T cell numbers in the interstitium far exceeded numbers in 
the airspaces, implicating interstitial effector CD8+ T cells as 
the major source of the proinflammatory cytokines liberated 
into the infected lungs. This concept received additional sup-
port from analysis of intracellular cytokine synthesis using the 
in vivo ICCS assay where, again, interstitial T cells were dem-
onstrated  to  be  the  predominant,  if  not  exclusive,  pro-
inflammatory cytokine producers. Using BM chimeras, we 
established that production of the proinflammatory cytokine 
IFN- by the effector CD8+ T cells was dependent on recog-
nition of CD45+ BM-derived cells and did not require MHC 
class I recognition of the infected respiratory epithelium. Fur-
thermore, depletion of CD11chi cells from the infected lung 
at the time of effector CD8+ T cell migration into the in-
fected  lung  markedly  decreased  proinflammatory  cytokine 
production by effector CD8+ T cells. In addition, the release 
of proinflammatory cytokines by effector CD8+ T cells was 
inhibited after blockade of the co-stimulatory ligands CD80 
and CD86. Finally, we provide several lines of evidence that 
suggest that infected respiratory epithelium can be recognized 
and type 1 alveolar epithelial cells (identified by cell surface 
T1- expression; Herold et al., 2008). Cells were identified   
as infected based on the simultaneous expression/detection   
of cell surface influenza HA and intracellular NP (Fig. S6,  
A and B). At 7 dpi, when infectious virus levels in the respira-
tory tracts of experimental and control infected chimeric ani-
mals  were  elevated  (Fig.  5  C),  virally  infected  respiratory 
epithelial cells were readily detected in both the experimental 
and control groups (Fig. 5, D and E). By 10 dpi, only very low 
numbers of residual infected cells were detected in the WT 
chimeric mice, but both WT → FAS/ and Perf/ → 
FAS/ mice retained substantial numbers of infected cells 
(which is consistent with the elevated infectious virus titer in 
the respiratory tract of these mice at this time point; Fig. 5 C). 
Infected cell numbers in WT → WT mice decreased to near 
undetectable levels by 14 dpi, but Perf/ → FAS/ mice 
retained substantial numbers of infected cells of both epithe-
lial cell types (Fig. 5, D and E), which is once again consistent 
with the data on residual virus titer in the lungs (Fig. 5 C). 
The number of infected epithelial cells in Perf/ → FAS/ 
mice did diminish over time, indicating that effector CD8+  
T cells may eventually clear virus in the absence of perforin- 
or  FAS-dependent  mechanisms,  suggesting  that  additional 
mechanisms may be in play (i.e., TNF-related apoptosis- 
inducing ligand [TRAIL]; Brincks et al., 2008).
A comparable pattern was observed for proinflammatory 
cytokine production (Fig. S6 C) and the presence of influenza 
antigen–expressing CD45+ cells (Fig. S6 D). Proinflammatory 
cytokine production by effector CD8+ T cells, as reflected in 
IFN-  release  into  the  BAL  fluid,  had  almost  ceased  in   
WT → WT by 10 dpi (Fig. S6 C). This decline in proinflam-
matory cytokine secretion was also reflected in the dimin-
ished number of antigen-bearing CD45+ mononuclear cells 
in the lungs at 10 dpi (Fig. S6 D). In contrast, Perf/ → 
FAS/ mice continued to produce IFN- both at 10 dpi and 
at diminished levels out to 14 dpi (Fig. S6 C) and retained   
detectable numbers of residual antigen-bearing CD45+ cells 
in the lungs (Fig. S6 D).
These  data  raised  the  intriguing  possibility  that  CD8+  
T  cell  engagement  with  antigen-bearing  CD45+CD11chi 
cells can lead to both proinflammatory cytokine release and 
cytolysis, whereas interactions with the infected respiratory 
epithelium results in cell lysis without triggering proinflam-
matory cytokine release by effector CD8+ T cells. To deter-
mine whether the differential CD8+ T cell effector activity 
could be influenced by the infected target cell type, we co-
cultured CD8+ T cell effectors isolated from the influenza-
infected lungs with influenza-infected cell types representing 
hematopoietic (CD45+) and nonhematopoietic cell lineages 
(CD45). After co-culture, we investigated transient up- 
regulation of CD107a/b as a marker for T cell cytolytic gran-
ule exocytosis (a measure of TCR engagement resulting in   
T cell cytolysis; Betts et al., 2003) and IFN- synthesis by 
ICCS (as a measure of TCR engagement proinflammatory 
cytokine production). The influenza-infected CD45 type II 
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Sun et al., 2009) and may not be essential for virus 
clearance from the respiratory tract (Lukacher et al., 
1984; Graham et al., 1993; Hussell et al., 2001). We 
found that proinflammatory cytokine production by 
the influenza-specific effector CD8+ T cells was de-
pendent solely on the recognition of CD45+ (BM 
derived) cells infiltrating the infected lungs (Fig. 2). 
Several lines of evidence, most notably the in vivo 
ICCS assay, suggested that this interaction between 
the effector CD8+ T cells and the APCs leading to 
cytokine production was occurring predominantly, if 
not  exclusively,  within  the  pulmonary  interstitium 
(Fig. 1). Cellular ablation analysis suggested that the 
predominant APCs in the infected lung interstitium 
express  CD11c  (Fig.  3)  and  appear  in  preliminary 
analyses to be inflammatory mononuclear cells of the 
DC lineage (not depicted). Of note, the ablation of 
this cell type in vivo did not affect infectious virus 
elimination from the infected lungs. Furthermore, al-
though not formally evaluated in this study, we be-
lieve that the CD45+CD11chi interstitial APC likely 
presents processed viral antigen to the effector CD8+ 
T cells in vivo both by direct infection (Hao et al., 2008) and 
by uptake of viral antigen and presentation via exogenous 
processing pathways (Albert et al., 1998).
Respiratory epithelial cells are a critical target of influenza 
virus as these cells are the major cell type in the lungs that are 
productively  infected  by  most  type A  influenza  viruses   
(La Gruta et al., 2007). Thus, elimination of virus-infected respi-
ratory epithelial cells (along with neutralization of infectious 
virions) is essential for recovery from infection. Our findings, 
both in vivo and in vitro, suggest that the encounter between 
effector CD8+ T cells and antigen-bearing CD45 cell types, 
such as the influenza-infected respiratory epithelium, results 
in minimal proinflammatory cytokine production; however, 
early analysis from our laboratory indicated that the interaction 
and destroyed by effector CD8+ T cells but that this inter-
action does not lead to proinflammatory cytokine production 
by the effector CD8+ T cells.
A hallmark of the host response to influenza virus is the 
potent proinflammatory cytokine/chemokine response and 
the attendant inflammation in the respiratory tract elicited by 
infection. Effector molecules contributed by both innate and 
adaptive immune cells can contribute to this proinflammatory 
cytokine response. Although this proinflammatory response in 
the respiratory tract to influenza infection may aid recovery 
(Wiley et al., 2001), there is considerable evidence to suggest 
that this response may also be a major contributor to the pul-
monary injury associated with influenza infection (Peper and 
Van Campen, 1995; Hussell et al., 2001; La Gruta et al., 2007; 
Figure 6.  CD8+ T cell effector activities upon co-culture 
with influenza-infected hematopoietic and nonhematopoi-
etic cells. (A and B) Lung suspensions of infected BALB/c mice 
(8 dpi) were collected and pooled. CD8+ cells were positively 
selected via MACS bead separation. CD8+ cells (effectors) were 
co-cultured with influenza-infected cells (targets) in indicated 
effector/target ratios ± -CD107a/b (FITC). CD8+ T cell degranu-
lation (CD107a/b+; A) and IFN-–producing CD8+ T cells after  
co-culture (B) are shown. Percentage max is the proportion of 
effector activity with respect to maximum production of effector 
activity within one experiment. Four independent experiments 
(two to three pooled mice/experiment) as mean ± SEM are 
shown. (C) Lung suspensions of infected BALB/c mice (8 dpi) 
were co-cultured in a 1:1 ratio with influenza-infected BMDCs 
for 6 h in the presence of isotype or blocking CD80 and CD86 
antibodies. Representative flow profiles (right) and percentage 
(left) of IFN-+CD8+ T cells after in vitro restimulation are 
shown. Two independent experiments (n = 5) as mean ± SEM are 
shown. A paired t test was used to test statistical significance. 
(A–C) Considered a significant difference at *, P < 0.05.JEM VOL. 208, January 17, 2011 
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but not proinflammatory cytokine production was initially 
unexpected but, in retrospect, not surprising. Studies over the 
past one to two decades have amply demonstrated a hierarchy 
of responses of T cells to antigen receptor engagement and co-
stimulation based on strength of stimulus, with cell-mediated 
cytotoxicity representing one of the easiest effector responses 
to elicit, whereas responses like antigen-dependent  T cell cyto-
kine production require a stronger stimulus (Valitutti et al., 
1996; Hemmer et al., 1998). Accordingly, influenza-infected 
CD45 respiratory epithelial cells, which express the requisite 
viral peptide–MHC complexes but do not express the rele-
vant co-stimulatory ligands, would only stimulate the acti-
vation  of  perforin/FasL  cytolytic  machinery  after TCR 
engagement on effector CD8+ T cells. Of note, because respi-
ratory epithelial cells are reported to express molecules that 
can negatively regulate host immune/inflammatory responses 
(Stanciu et al., 2006; Mayer et al., 2008), we cannot exclude 
the possibility that, in vivo at least, negative signals delivered 
by infected respiratory epithelium can also act to limit the 
range of effector activities available to the CD8+ T cells enter-
ing the airspaces after TCR engagement.
In conclusion, in this study, we demonstrate that effector 
CD8+ T  cell–mediated  cytolysis-dependent  elimination  of 
virally infected cells (and associated virus clearance) and pro-
inflammatory cytokine production by the T cells are differen-
tially regulated in vivo. Cytolytic machinery can be activated 
by both antigen-bearing CD45+ and CD45 APCs (target 
cells). In contrast, in the influenza-infected lungs, only CD45+ 
(predominately CD11chi inflammatory mononuclear) APCs 
(target cells) can trigger proinflammatory cytokine produc-
tion by effector CD8+ T cells. T cell–mediated proinflamma-
tory cytokine production is, in part at least, dependent on 
co-stimulatory interactions mediated by CD80 and CD86. 
Blockade of CD80 and CD86 has no effect on virus elimina-
tion. These findings open up the possibility of therapeutic inter-
vention in severe influenza infection by selectively inhibiting 
within the infected respiratory tract signaling events between 
effector T cells and APCs/target cells (i.e., CD45+ inflamma-
tory mononuclear cells), which induce excess proinflamma-
tory cytokine/chemokine responses without affecting T cell/ 
target cell encounters resulting in virus elimination.
MATERIALS AND METHODS
Mice and infection. Female BALB/c (H-2d) and C57BL/6 (H-2b) were 
purchased from the National Cancer Institute and The Jackson Laboratory. 
Tg  mice  expressing  nonhuman  primate  DTR  under  the  control  of  the 
mouse CD11c promotor (C.FVB-tgItgax-DTR/EGFP 57Lan/J, BALB/c back-
ground), Thy-1.1 clone 4 (CL-4) tg mice (BALB/c background), homozy-
gous  FASlpr  mice  (C57BL/6  background),  perforin/  mice  (C57BL/6 
background),  and  Rag1/  mice  (C57BL/6  background)  were  obtained 
from The Jackson Laboratory. IFN- reporter (YETI) mice (Mayer et al., 
2005; C57BL/6 background) were a gift from M. Mohrs (Trudeau Institute, 
Saranac Lack, NY). Kb/Db/ mice (Thy-1.1 C57BL/6 background) were 
a gift from A. Lukacher (Emory University, Atlanta, GA). To delete CD11chi 
cells, DTR tg mice were injected i.n. with 200 ng DTx/50 µl PBS (Sigma-
Aldrich). All mice were housed in a pathogen-free environment and used at 
8–14 wk of age for all experiments. All animal experiments were performed 
in accordance with protocols approved by the University of Virginia Animal 
of effector CD8+ T cells with virus influenza-infected cells in 
the lungs was highly specific (Lukacher et al., 1984). In repris-
ing and extending an earlier analysis using BM chimeras to 
evaluate the contribution of cytolytic effector mechanisms   
in virus clearance (Topham et al., 1997), we were able to con-
firm the importance of the perforin and Fas/FasL cytolysis 
mechanisms in virus clearance and to extend this analysis to 
formally demonstrate for the first time the dependence on 
these mechanisms for the elimination of influenza-infected 
respiratory epithelial cells (Fig. 5). These findings, along with 
our companion in vitro findings, reinforce the view that the 
infected respiratory epithelium is indeed recognized by effec-
tor CD8+ T cells, but this interaction selectively triggers only 
the activation of cytolytic effector machinery. It is notewor-
thy that the simultaneous elimination of both the perforin- 
and Fas/FasL-dependent cytolysis machinery serves to delay 
rather  than  prevent  the  elimination  of  virus-infected  cells 
(Fig.  5). Thus,  other  cytolysis-dependent  mechanisms  (i.e., 
TRAIL–TRAIL-L interactions; Brincks et al., 2008) likely 
contribute to the overall cytolytic process used by effector 
CD8+ T cells to eliminate virally infected cells.
The requirement for co-stimulation in the activation of 
naive T cells (both CD4+ and CD8+ T cells) and in the differ-
entiation of activated T cells into various types of effector 
cells  has  been  well  established  from  many  model  systems 
(Locksley et al., 2001; Sharpe and Freeman, 2002), including 
studies on the role of the co-stimulatory ligands in the induc-
tion of influenza-specific CD8+ T cell responses (Bertram   
et al., 2002; Humphreys et al., 2003;  Vidric et al., 2005). In this 
study, we examined the impact of blockade of CD80 and 
CD86 on proinflammatory cytokine production by effector 
CD8+ T cells in the infected lungs, that is, after the influenza-
specific CD8+ T cells had undergone activation, proliferation, 
and differentiation in the draining LNs (Lawrence and Braciale, 
2004) and subsequently begun their migration to the site of 
infection (i.e., the infected lungs). We found that in vivo block-
ade of CD80 and CD86 resulted in markedly diminished 
proinflammatory cytokine production (i.e., IFN-) 24 h after 
co-stimulatory ligand blockade, both in BAL fluid IFN- and 
via the in vivo ICCS assay (Fig. 4). Importantly, this inhibition 
of co-stimulation of effector T cells had no effect on infec-
tious virus titer in the infected lungs. Because the interstitial 
CD45+ cells (including CD11chi inflammatory mononuclear 
cells) express high levels of CD80 and CD86, whereas respira-
tory epithelial cells do not (Fig. 5 A), our results suggest that 
inhibition of co-stimulation through co-stimulatory ligand 
blockade acts to suppress proinflammatory cytokine produc-
tion with minimal effect on the elimination of virus-infected 
respiratory epithelium. More importantly, our results as well 
as the findings of Humphreys et al. (2003) altering the host 
response to influenza infection by inhibiting OX-40–OX40-L 
interactions raised the possibility that we may be able to sup-
press excess proinflammatory cytokine responses and associ-
ated pulmonary injury without affecting virus clearance.
Our observation that CD45 cells, including respiratory 
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or isolated CD8+ cells (see Adoptive Transfer for details) were co-cultured 
with infectious virus–pulsed P815 cells or BMDCs (10 multiplicity of infec-
tion) in a 1:1 ratio (unless indicated otherwise). We co-cultured cells for 6 h 
at 37°C in DME + 5% FCS in the presence of 1.6 µl ml1 Golgi-Stop (BD). 
The percentage of CD8+ T cells stimulated to produce IFN- as determined 
by FACS analysis was used to calculate the number of total antigen-specific 
polyclonal CD8+ T cells. To measure the capacity of polyclonal CD8+ T cells 
to degranulate, single-cell suspensions from BALB/c mice were co-cultured 
with infectious virus–pulsed P815 cells (1 multiplicity of infection; or other 
noted cellular target) in a 1:1 ratio. We co-cultured cells for 6 h at 37°C in 
DME + 5% FCS in the presence of 1.6 µl ml1 Golgi-Stop (BD) +   
-CD107a/b (FITC; Betts et al., 2003). We generated BMDCs as previously 
described (Lutz et al., 1999). For CD80 and CD86 blockade, in vitro co- 
cultured  cells  were  stimulated  in  media  containing  CD80-specific  mAb 
(clone 16-10A1; Bio X Cell) + CD86-specific mAb (clone GL-1; Bio X 
Cell) or with isotype antibody (2 µg/ml). MLE-Kd cells were a gift from   
R. Enelow (Dartmouth Medical School, Hanover, NH).
In vivo intracellular cytokine synthesis assay. Cytokine-producing cells 
in vivo were measured on a previously described protocol with modifications 
(Liu and Whitton, 2005). In brief, on the proscribed dpi, 50 µg BFA (Sigma-
Aldrich) was administered i.n. or 500 µg monensin (Sigma-Aldrich) was ad-
ministered i.p. 6 h later, we prepared lung single-cell suspensions in the 
presence of the respective protein transport inhibitor on ice. Tissues were not 
collagenase digested in this procedure. Cells were then fixed, permeabilized, 
and  stained  for  intracellular  cytokines  as  previously  described  (Kim  and   
Braciale, 2009).
Irradiation and BM transplantation. Mice were irradiated with 9.4 Gy 
and, within 24 h, i.v. injected with RBC-lysed BM cells (1–2 × 106) prepared 
from uninfected C57BL/6, Rag/, or perforin/ mice.
Adoptive transfer. For CD8+ T cell isolation, cell suspensions from spleen 
or lung were isolated by positive selection after incubation with anti-CD8 
magnetic microbeads using MACS cell sorter (Miltenyi Biotec) in accor-
dance with the manufacturer’s instruction. A total of 2 × 105 isolated splenic 
naive CL-4 tg T cells were i.v. injected into the tail vein of Thy-mismatched 
congenic mice at the indicated time points. For adoptively transferring T cell 
effectors, a total of 5 × 105 isolated CD8+ cells from a 6 dpi lung were i.v. in-
jected into the tail vein of Thy-mismatched congenic mice at the indicated 
time points. Adoptively transferred cells were identified as FSCloSSCloCD45+ 
Thy1.2Thy1.1+CD4CD8+ in flow cytometric experiments. For reconsti-
tuting immune-deficient chimeric mice, 50 × 106 WT splenocytes were i.v. 
injected into the tail vein of Rag1//MHC chimeric mice.
CD80 and CD86 blockade. At noted dpi with influenza, we injected mice 
i.p. with 500 µg CD80-specific mAb (clone 16-10A1) and 500 µg CD86-
specific mAb (clone GL-1) or with 1 mg of isotype antibody.
Statistics. Unless otherwise noted, a two-tailed Mann-Whitney test was 
used to compare two treatment groups. Groups larger than two were ana-
lyzed with Kruskal-Wallis one-way analysis of variance test. These statistical 
analyses were performed using Prism3 software (for Macintosh; GraphPad 
Software, Inc.). Results are expressed as means ± SEM. Values of P < 0.05 
were considered statistically significant.
Online supplemental material. Fig. S1 shows the impact of T cell ablation   
on proinflammatory cytokine production and influenza virus clearance in 
the lung. Fig. S2 shows the optimization of the in vivo ICCS assay. Fig. S3 
shows airspace and interstitial CD8+ T cell effector activity after in vitro re-
stimulation. Fig. S4 shows YFP expression in airspace and interstitial CD8+  
T cells in influenza-infected IFN- reporter mice and CD8+ T cell IFN- 
production in the adoptive transfer clone 4 model. Fig. S5 shows the migra-
tion, viral content, and CD11c expression of inflammatory mononuclear 
cells during influenza infection and the impact of acute CD80 and CD86 
Care and Use Committee. Type A influenza viruses A/PR/8/34 (H1N1) or 
A/X31 (H3N2) were grown in day 10 chicken embryo allantoic cavities as 
described previously (Lawrence and Braciale, 2004). Unless noted otherwise, 
mice were infected with 250 egg infectious doses (EID50) of A/PR/8/34 i.n. 
(corresponding to a 0.1 LD50 dose) or with 10,000 EID50 A/X31 i.n.
Preparation of tissue and single-cell suspension. Mice were euthanized 
via cervical dislocation, and 1 ml BAL fluid was quickly collected (as de-
scribed in BAL fluid cytokine determination). Lungs were perfused via the 
right ventricle of the heart with 3 ml PBS to remove blood lymphocytes 
from the vasculature. Subsequently, lung tissue was minced and enzymatically 
digested with type II collagenase (37°C for 30 min; Worthington), followed 
by passing through a steel screen. RBCs in the cell suspensions were lysed 
using ammonium chloride. Cells were counted using a hemacytometer after 
exclusion of dead cells using Trypan blue dye and resuspended at appropriate 
concentrations for each experiment.
Antibodies. The following mAbs were purchased from BD or eBioscience 
(unless otherwise stated), as conjugated to FITC, Alexa-488, PE, PE-Cy7, 
PerCP-Cy5.5, APC, Alexa Fluor 647, APC–Alexa Fluor 780, or biotin: CD4 
(GK1.5), CD4 (L3T4), CD8- (53–6.7), CD11a (2D7), CD11b (M1/70), 
CD11c (HL3), CD19 (1D3), CD25 (PC61), CD43 (1B11), CD44 (IM7), 
CD45 (30-F11), CD49b (DX5), CD49d (R1-2), CD62L (MEL-14), CD69 
(H1.2F3), CD80 (16-10A1), CD86 (GL-1), CD90.1 (OX-7), CD90.2 (53–2.1), 
CD107a  (1D4B),  CD107b  (ABL-93),  Gr-1  (RB6-8C5),  SigLecF  (E50-
2440), F4/80 (C1:A3; Invitrogen), Ly6G (1A8), Ly6C (AL-21), Ep-CAM 
(G8.8; BioLegend), T1- (clone 500; Abcam), H-2Kb (AF6-88.5), H-2Kd 
(SF1-1.1), I-Ad (AMS-32-1), MIP-1 (R&D Systems), IL-2 (18175A), IFN- 
(XMG1.2), TNF (MP6-XT22), HA (gift from J. Yewdell, National Institute 
of Allergy and Infectious Diseases, Bethesda, MD), influenza polymerase tet-
ramer (Db; B16; Trudeau Institute), and isotype control antibodies. Anti–
mouse CD16/32 used for Fc receptor blocking was isolated and purified in 
our laboratory. Anti–mouse influenza NP (H16) was isolated and purified in our 
laboratory. For biotinylated mAbs, samples were incubated with streptavidin–
PerCp-Cy5.5 or -PE.
Flow cytometry analysis and intracellular staining. Cells were suspended 
in FACS buffer containing PBS, 2% FBS, 10 mM EDTA, and 0.01% NaN3. 
Cells suspensions were blocked with anti–mouse CD16/32 and then incubated 
with specific mAbs or isotype/fluorescence minus one controls for 30 min at 
4°C. Surface maker staining and ICCS were performed described previously 
(Kim and Braciale, 2009). Flow cytometry was performed on FACS Canto flow 
cytometers (BD), and data were analyzed using FlowJo (Tree Star, Inc.).
BAL fluid cytokine determination. We obtained BAL fluid by making an 
incision in the trachea and subsequently flushing the airways three times with 
a single use of 1 ml sterile PBS. We spun down the BAL fluid–associated cells 
and collected supernatants for ELISA (BD). ELISA was performed according 
to the manufacturer’s manuals.
T cell depletion in vivo. At noted dpi with influenza, we injected mice 
with 200 µg CD8-specific mAb (clone 2.43; BioExpress) and/or 500 µg 
CD4-specific mAb (clone GK1.5; BioExpress) i.p.
Viral titer. We monitored lung viral titers via endpoint dilution assay and 
expressed them as tissue culture ID50 (TCID50). We incubated Madin-Darby 
canine kidney cells (American Type Culture Collection) with 10-fold dilu-
tions of BAL fluid from influenza virus–infected mice in serum-free DME 
culture. After 3–4-d incubation at 37°C in a humidified atmosphere of 5% 
CO2,  supernatants  were  collected  and  mixed  with  a  half-volume  of  1% 
chicken RBCs (University of Virginia Veterinary Facilities). Hemagglutina-
tion patterns were read thereafter, and TCID50 values were calculated.
In vitro CD8+ T cell restimulation assay. For identification of antigen-
specific polyclonal CD8+ T cells, single-cell suspensions from BALB/c mice JEM VOL. 208, January 17, 2011 
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